Bass, Berry & Sims served as lead counsel representing an emergency department provider and other defendants in a qui tam lawsuit alleging that violation of licensure laws caused submission of false claims. The district court dismissed the allegations against the emergency department provider on the grounds that the alleged regulatory violation did not satisfy standard for FCA materiality set forth in Supreme Court’s Escobar decision. U.S. ex rel. Taylor v. Boyko, 2019 WL 2423283 (S.D. W. Va. Jun. 6, 2019).
U.S. ex rel. Taylor v. Boyko, M.D. et al.
You Also May Be Interested In:
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Representation of LogistiCare in its $80 million acquisition of National MedTrans, a single source Non-Emergency Medical Transportation (NEMT) benefit management company focused on delivering services to managed care organizations and governmental entities throughout the United States, as well as the extension of its revolving credit facilities from $200 million to $225 million
Representation of Spring Fertility, a leading provider of fertility care in Northern California backed by Wildcat Capital, in its acquisition of Genesis Fertility Centre, a Vancouver, British Columbia-based fertility clinic